Confidential Information A. During and for a period of ten (10) years after the expiration or early termination of this Agreement, Provider and Principal Investigator shall retain in confidence all test articles and proprietary data and/or information obtained from Sponsor or generated pursuant to the Study including, but not limited to, the Protocol, the investigator's brochure, interim results and any other information or material disclosed under confidential disclosure agreements previously entered into between the parties ("Confidential Information"). Any written Confidential Information provided by Sponsor shall be marked „confidential“ (or with word of similar import). Confidential Information provided by Sponsor not marked as such shall be confidential if a reasonable person would consider such document to be confidential based on the nature of such information and circumstances of disclosure. This restriction shall not apply to Confidential Information that: příslušného regulatorního orgánu. Hlavní zkoušející také poskytne Zadavateli kopie všech dokumentů, které budou předány kterémukoli inspektorovi nebo auditorovi. V případě, že bude FDA nebo jiný regulatorní orgán požadovat přijetí jakéhokoli opatření za účelem řešení jakékoli obsílky, Hlavní zkoušející a Poskytovatel přijmou po konzultaci se Zadavatelem opatření nezbytné pro řešení takovéto obsílky a souhlasí, že budou spolupracovat se Zadavatelem, pokud jde o jakoukoliv takovou obsílku nebo opatření přijaté v souvislosti s ní. 8. Náklady a platby Zadavatel se zavazuje (případně prostřednictvím autorizovaneho zástupce) uhradit poskytovateli za provádění Studie, tj. za návštěvy, vyšetření a další služby poskytnuté na základě této smlouvy, odměnu v souladu s rozpočtem pro Studii, který je připojen jako Příloha B a začleněn do této Smlouvy odkazem. Částky stanovené v rozpočtu jsou příslušnými stranami považovány za přiměřenou odměnu za práci provedenou danou stranou. Platby ze strany Zadavatele za služby poskytnuté Poskytovatelem a Hlavním zkoušejícím na základě této Smlouvy (i) představují přiměřenou tržní hodnotu za takové služby, (ii) byly sjednány jako transakce v běžných obchodních vztazích a (iii) nebyly určeny způsobem, který zohledňuje objem nebo hodnotu jakýchkoliv doporučení nebo jakkoliv jinak generovanou obchodní spolupráci mezi stranami. Za vykonanou práci nebo vynaložené výdaje, za xxx xx Zadavatel povinen provést platbu, nebude Poskytovatel a Hlavní zkoušející požadovat z jakéhokoliv zdroje dodatečnou xxxxxx. ...
Confidential Information A. During and for a period of ten (10) years after the expiration or early termination of this Agreement, Institution and Principal Investigator shall retain in confidence all test articles and proprietary data and/or information obtained from Sponsor or generated pursuant to the Study including, but not limited to, the Protocol, the investigator's brochure, interim results and any other information or material disclosed under confidential disclosure agreements previously entered into between the parties ("Confidential Information"). This restriction shall not apply to Confidential Information that: (i) is or becomes public knowledge (through no fault of Institution or Principal Investigator); or (ii) is lawfully made available to Institution or Principal Investigator by an independent third party owing no obligation of confidentiality to Sponsor with regard thereto (and such lawful right can be properly demonstrated by Institution or Principal Investigator); or (iii) is already in Institution's or Principal Investigator’s possession at the time of receipt from Sponsor (and such prior possession can be properly demonstrated by Institution or Principal Investigator); or (iv) is published in accordance with the express terms of this Agreement. B. Institution may disclose Confidential 8. Náklady a platby Rozpočet pro Studii je připojen jako příloha B a začleněn do této Smlouvy odkazem. Platby stanovené v těchto rozpočtových formulářích jsou stranami této Smlouvy považovány za přiměřenou odměnu za práci provedenou danou stranou. Platby ze strany Zadavatele za služby poskytnuté Zdravotnickým zařízením a Hlavním zkoušejícím na základě této Smlouvy (i) představují přiměřenou tržní hodnotu za takové služby, (ii) byly sjednány jako transakce v běžných obchodních vztazích a (iii) nebyly určeny způsobem, který zohledňuje objem nebo hodnotu jakýchkoliv doporučení nebo jakkoliv jinak generovanou obchodní spolupráci mezi stranami. Za vykonanou práci nebo vynaložené výdaje, za xxx xx Zadavatel povinen provést platbu, nebude Zdravotnické zařízení a Hlavní zkoušející požadovat z jakéhokoliv zdroje dodatečnou úhradu. 9.
Confidential Information A. During and for a period of ten (10) years after the expiration or early termination of this Agreement, Institution and Principal Investigator shall retain in confidence all test articles and proprietary data and/or information obtained from Sponsor or generated pursuant to the Study including, but not limited to, the Protocol, the investigator's brochure, interim results and any other information or material disclosed under confidential disclosure agreements previously entered into between the parties ("Confidential Information"). This restriction shall not apply to Confidential Information that: (i) is or becomes public knowledge (through no fault of Institution or Principal Investigator); or (ii) is lawfully made available to Institution or Principal Investigator by an independent third party owing no obligation of confidentiality to Sponsor with regard thereto (and such lawful right can be properly demonstrated by Institution or Principal Investigator); or (iii) is already in Institution's or Principal Investigator’s possession at the time of receipt from Sponsor (and such prior possession can be properly demonstrated by Institution or Principal Investigator); or (iv) is published in accordance with the express terms of this Agreement. B. Institution may disclose Confidential Information to the extent it is required by law, regulation, rule, act or order of any governmental authority or agency. To permit Sponsor an opportunity to intervene by seeking a protective order or other similar order, in order to limit or prevent disclosures of Confidential Information, Institution or Principal Investigator shall immediately notify Sponsor, in writing, if it is requested by a court order or a governmental authority or agency to disclose Confidential Information in Institution's or Principal Investigator’s possession and thereafter Institution or Principal Investigator shall disclose only the minimum Confidential Information required to be disclosed in order to comply, whether or not a protective order or other similar order is obtained by Sponsor. C. Subject to applicable legal and regulatory requirements, Institution and Principal Investigator agree to promptly return to Sponsor, upon its request, all Confidential Information obtained from Sponsor or belonging to Sponsor pursuant to this Agreement; provided, however, that Institution's legal counsel may retain one copy of Confidential Information in a secure location for purposes of identifying Institution's o...
Confidential Information A. The Executive agrees that she shall hold in strict confidence and shall not at any time during or after her employment with the Company, directly or indirectly, (i) reveal, report, publicize, disclose, or transfer any Confidential Information (as described below) or any part thereof to any person or entity, (ii) use any of the Confidential Information or any part thereof for any purpose other than in the course of her duties on behalf of the Company, or (iii) assist any person or entity other than the Company to secure any benefit from the Confidential Information or any part thereof. All Confidential Information (regardless of the medium retained) and all abstracts, summaries or writings based upon or reflecting any Confidential Information in the Executive's possession shall be delivered by the Executive to the Company upon request therefore by the Company or automatically upon the expiration of the Term or termination of this Agreement.
Confidential Information A. The Consultant acknowledges that he will acquire information about certain matters and things which are confidential to the Company ("Confidential Information"), and which information is the exclusive property of the Company including but not limited to the following: i) product design and manufacturing information and computer programs, codes, materials, prototypes, products samples, analyses, reports;
Confidential Information A. Neither Party will disclose Confidential Information from the other Party without the prior written consent of the other Party except where (i) the disclosure is required by applicable law or regulation or by an order of a court or other governmental body having jurisdiction after giving reasonable notice to the other Party with adequate time for such other Party to seek a protective order; (ii) if in the opinion of counsel for such Party, disclosure is advisable under any applicable securities laws regarding public disclosure of business information; or (iii) the disclosure is reasonably necessary and is to that Party’s, or its Affiliates’, employees, officers, directors, attorneys, accountants and other advisors, or the disclosure is otherwise necessary for a Party to exercise its rights and perform its obligations under this Agreement, so long as in all cases referenced above, in this subsection (iii), the disclosure is no broader than necessary, and the person or entity who receives the disclosure agrees prior to receiving the disclosure to keep the information confidential (except with regards to disclosures to a court or arbitrator in connection with an action to enforce a Party’s rights under this Agreement). Each Party is responsible for ensuring that any Confidential Information of the other Party that the first Party discloses pursuant to this Agreement (other than disclosures pursuant to subsections (i) and (ii) and (iii) (but with respect to (iii), only with regard to disclosures to a court or similar body necessary for a Party to exercise its rights under this Agreement) above that cannot be kept confidential by the first Party) is kept confidential by the person receiving the disclosure to the same extent that the receiving Party must keep the information confidential. b. Neither Customer nor Equinix grants the other Party the right to use its trademarks, service marks, trade names, logos, copyrights, or other intellectual property rights or other designations in any promotion, publication, or press release without the prior written consent of the other Party in each case. Notwithstanding the restrictions set forth in this Agreement during the Term. (i) Equinix may issue a press release announcing Customer’s entry into the IBX Centers without obtaining Customer’s consent; and (ii) either Party may publicly refer to the other Party, orally and in writing, as a customer or vendor of services of or to the other Party, as the case may be, without...
Confidential Information A. During and for a period of ten (10) years after the expiration or early termination of this Agreement, Institution and Principal Investigator shall retain in confidence all test articles and proprietary data and/or information obtained from Sponsor or generated pursuant to the Study including, but not limited to, the Protocol, the investigator's brochure, interim results and any other information or material disclosed under confidential disclosure agreements previously entered into between the parties ("Confidential Information"). This restriction shall not apply to Confidential Information that: (i) is or becomes public knowledge (through no fault of Institution or Principal Investigator); or (ii) is lawfully made available to Institution or Principal Investigator by an independent third party owing no obligation of confidentiality to Sponsor with regard thereto (and such lawful right can be properly demonstrated by Institution or Principal Investigator); or (iii) is already in Institution's or Principal Investigator’s possession at the time of receipt from Sponsor (and such prior possession can be properly demonstrated by Institution or Principal Investigator); or (iv) is published in accordance with the express terms of this Agreement. B. Institution may disclose Confidential Information to the extent it is required by law, regulation, rule, act or order of any governmental authority or agency. To permit Sponsor an opportunity to intervene by seeking a protective order or other similar order, in order to limit or ze strany Zadavatele za služby poskytnuté Zdravotnickým zařízením a Hlavním zkoušejícím na základě této Smlouvy (i) představují přiměřenou tržní hodnotu za takové služby, (ii) byly sjednány jako transakce v běžných obchodních vztazích a (iii) nebyly určeny způsobem, který zohledňuje objem nebo hodnotu jakýchkoliv doporučení nebo jakkoliv jinak generovanou obchodní spolupráci mezi stranami. Za vykonanou práci nebo vynaložené výdaje, za xxx xx Zadavatel povinen provést platbu na účet Zdravotnického zařízení, nebude Zdravotnické zařízení a Hlavní zkoušející požadovat z jakéhokoliv zdroje dodatečnou úhradu. Zdravotnické zařízení se zavazuje uhradit Hlavnímu zkoušejícímu XXX z netto odměny za klinické hodnocení poskytnuté Zadavatelem. 9.
Confidential Information A. During and for a period of ten (10) years after the expiration or early termination of this Agreement, Provider of Medical Services and Principal Investigator shall retain in confidence all test articles and proprietary data and/or information obtained from Sponsor or generated pursuant to the Study including, but not limited to, the Protocol, the investigator's brochure, interim results and any other information or material disclosed under confidential disclosure agreements previously entered into between the parties ("Confidential Information"). This restriction shall not apply to Confidential Information that: (i) is or becomes public knowledge (through no fault of Provider of Medical Services or Principal Investigator); or (ii) is lawfully made available to Provider of Medical Services or Principal Investigator by an independent third party owing no obligation of confidentiality to Sponsor with regard thereto (and such lawful right can be properly demonstrated by Provider of Medical Services or Principal Investigator); or (iii) is already in Provider of Medical Services’or Principal Investigator’s possession at the time of receipt from Sponsor (and such prior possession can be properly demonstrated by Provider of Medical Services or Principal Investigator); or (iv) is published in accordance with the express terms of this Agreement. B. Provider of Medical Services may disclose Confidential Information to the extent it is required by law, regulation, rule, act or order of any governmental authority or agency. To permit Sponsor an opportunity to intervene by seeking a protective order or other similar order, in order to zkoušejícím na základě této Smlouvy (i) představují přiměřenou tržní hodnotu za takové služby, (ii) byly sjednány jako transakce v běžných obchodních vztazích a (iii) nebyly určeny způsobem, který zohledňuje objem nebo hodnotu jakýchkoliv doporučení nebo jakkoliv jinak generovanou obchodní spolupráci mezi stranami. Za vykonanou práci nebo vynaložené výdaje, za xxx xx Zadavatel povinen provést platbu, nebude Poskytovatel zdravotních služeb a Hlavní zkoušející požadovat z jakéhokoliv zdroje dodatečnou xxxxxx. 0.
Confidential Information A. In this Agreement “Confidential Information” means information proprietary to the Employer or RB Global that is not publicly known or available, including but not limited to
Confidential Information A. Except with the express written consent of San Xxxxxxx or as otherwise herein expressly provided, the Consultant shall not, either during the Term of this Agreement or at any time thereafter, disclose or cause to be disclosed, either directly or indirectly, any of the Confidential Information in any manner, to anyone other than to the officers, directors and management of San Xxxxxxx. b) The Confidential Information shall only be disclosed to Consultants Representatives on a "need to know" basis. Consultant shall ensure that all such Persons having access to the Confidential Information comply with the provisions of this Agreement. c) The confidentiality obligations hereunder shall not apply to any of the Confidential Information that the Consultant can demonstrate is available to the public other than as a result of disclosure by the Consultant or Consultant's Representatives. d) The confidentiality obligations hereunder shall cease to apply to any Non-Acquired Prospects one year from the date that the applicable Prospect Letter was presented to San Xxxxxxx by the Consultant. Between the fifth and twelfth months (inclusive) from the date that a Prospect Letter for a Non-Aquired Prospect was presented to San Xxxxxxx, the Consultant shall be entitled to disclose Confidential Information to a third party in exercising its rights under Subsection 3.3 b). e) The Consultant shall be entitled to disclose Confidential Information to a court of competent jurisdiction or to any regulatory body having jurisdiction, provided that: (i) The Consultant shall take reasonable steps to maintain the confidentiality of the Confidential Information by the court or regulatory body; and (ii) The Consultant shall provide San Xxxxxxx with immediate written notice of any request for disclosure.
